Alignment Healthcare, Inc.
ALHC · Price history
Price at last available close
$8.06
−$0.10 (-1.23%) 1M
2026-10-29
Tap or drag sideways to inspect a price. Use two fingers to compare automatically. Release to scroll. Use Shift + arrow keys to compare with a keyboard.
Company & revenue
About Alignment Healthcare, Inc.
Primary reporting period: 2025-12-31 · Research updated Oct 12, 2026. A research update is not a new financial filing.
Who they are
Alignment Healthcare, Inc. is a technology-driven Medicare Advantage provider operating a healthcare platform focused squarely on the consumer. This organization delivers personalized medical services across the United States, primarily for elderly individuals and others requiring specific support, leveraging its suite of Medicare Advantage plans. The company directly owns and operates Medicare Advantage programs in California, North Carolina, and Nevada.
How they make money
Alignment Healthcare operates as a Medicare Advantage plan provider, generating revenue primarily through monthly premiums paid by the Centers for Medicare & Medicaid Services (CMS) based on the number of enrolled members and their health risk profiles. The company manages medical costs through a coordinated care model, utilizing its proprietary technology platform, AVA, to optimize clinical outcomes and operational efficiency for its senior member population.
Products & services
The company offers Medicare Advantage health plans, including Health Maintenance Organization (HMO) and Preferred Provider Organization (PPO) products, designed for seniors.
Brands & revenue mix
The primary consumer-facing brand for the company's Medicare Advantage plans.
Separate brand revenue is not available in this research.Source
Revenue share is not unit sales or a best-seller ranking. Parent brands and included sub-brands can overlap; do not add overlapping rows.
Product / operating segments
No reconciled product or operating-segment revenue breakdown is available for the current research period. Company-wide revenue remains separate from segment disclosure.
Geographic revenue
No reconciled geographic revenue breakdown was confirmed for the current research period.
Customer types
- Medicare-eligible seniorsSource
Customer concentration
The company's revenue is primarily derived from contracts with the Centers for Medicare & Medicaid Services (CMS), which represents a significant concentration of its business as the primary payer for its Medicare Advantage plans.
Suppliers, materials & equipment
- Healthcare providers — The company partners with local providers to deliver coordinated care to its members; the specific names of these providers are not disclosed as individual suppliers.Source
Competitors
- UnitedHealth Group — Competes in the Medicare Advantage market.Source
- Humana — Competes in the Medicare Advantage market.Source
- CVS Health (Aetna) — Competes in the Medicare Advantage market.Source
- Elevance Health — Competes in the Medicare Advantage market.Source
- Cigna — Competes in the Medicare Advantage market.Source
Sources
Wall Street Score
Overall investment score · Quality, value, risk and opportunity
42
Weak
View category scores →
Company Quality
How good is the actual business—regardless of today’s stock price?
61
Fair
Financial Strength
38
Business Quality / Moat
89
Management
73
Growth Quality
74
Risk / Durability
14
Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.
Opportunity
Opportunity Score · How does the current price compare with estimated value?
43
Avoid
Based on current valuation, company quality, recent trends, and available market signals.
View score details →
Model Outlook
12-month model · What does the model think happens next?
57/100
Building Historical Record
Model Score 57/100 — estimates relative performance potential, distinct from the overall Wall Street Score and the separate Company Quality score.
Probability unavailable — the model has not produced a calibrated probability yet.
Click for full breakdown →
WSS View
The quick read
The overall Wall Street Score is low across its combined quality, valuation and risk inputs. This can reflect an expensive share price, business weaknesses, or both; check Company Quality and the category breakdown before drawing a conclusion.
At today’s price, the WSS valuation framework currently reads as less attractive based on the available valuation and market data.
The model outlook is currently moderate.
- •Asset quality scores strongly
- •Debt service risk
- •Valuation is a weaker part of the current profile
- •Debt / balance-sheet profile needs attention
Company-specific research
Questions worth answering for ALHC
These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.
- •Can ALHC maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
- •Is ALHC's positive free cash flow repeatable, or is the current level being helped by temporary working-capital or spending changes?
- •How is ALHC likely to use its cash advantage: reinvestment, acquisitions, debt reduction, dividends or buybacks?
- •What future growth or profitability would be needed to justify ALHC's current valuation?
Essential Investment Snapshot
Wall Street Score
42
Opportunity Score
43
Market Cap
$1.67B
P/E Ratio
40.9
EPS
$0.20
52-Week High
$25.12
52-Week Low
$7.37
Beta
1.11
Intrinsic Value
$7.68
Analyst Target
$19.00
Shares Outstanding
198.0M
Total Revenue
$4.58B
Total Debt
$330.5M
Dividend
No current dividend
Liquidation Value / Share
$1.34
Momentum & Volatility Signals
Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.
Weakening momentum
Elevated movement
A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.
A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.
Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.
Notices for ALHC
Detected from reported data — verify before acting.Debt service risk
Interest coverage is low (~0.9x). Earnings may be strained to cover interest expense.
Community Sentiment
0 active · 0 total callsNo personal call yet on ALHC.
Potential upside factors
- +Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
- +Proprietary technology platform (AVA).
- +High member retention rates.
- +Positive free cash flow may provide capacity to invest in growth.
Potential downside factors
- −Key risks may include competition, margin pressure, debt levels, valuation risk, and changes in demand within the Medical - Healthcare Plans industry.
- −Dependence on government funding (CMS).
- −Regulatory changes in the Medicare Advantage program.
These research factors come from saved company research and financial data, not community votes. They are starting points to verify against filings, not buy or sell recommendations.
Create a free account to make a call.
Scores
Click any score for full breakdownWas this stock page easy to understand?
One click helps us improve the research experience. This is not tied to an investment decision.
Score Changes
5 historical score records availablePrevious Score
40
Sep 8, 2026
Change
+1.8
points
Current Score
42
Oct 1, 2026
Category Changes
ALHC increased 1.8 points because Revenue improved by 4.6 points, Asset improved by 6.9 points, Capital improved by 4 points.
Positive Contributors
- + Revenue improved by 4.6 points
- + Asset improved by 6.9 points
- + Capital improved by 4 points
- + Valuation improved by 4.4 points
- + Buffett improved by 2.4 points
Projected Score
Projected Score
47
Projected Change
+5.2 points
Preliminary comparable-period financial changes suggest improvement of approximately 5.2 points. This is a projected estimate, not the official WallStreetScore.
Price vs. Value
Near Fair ValueCurrent Price
$8.06
Model Intrinsic Value
$7.68
Difference
+$0.38
+4.9% vs IV
Margin of Safety
-4.9%
Financial Charts
Revenue
Additional Metrics
Operating Cash Flow
Total Debt
Total Assets
Net Margin %
Free includes 3 annual periods plus available TTM; Premium includes up to 10 annual periods. History depends on available company filings. Swipe the table horizontally to see older periods. A dash means unavailable, not zero.
| Line Item | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.58B | $3.95B | $2.70B | $1.82B | ···· | ···· | ···· | ···· |
| Cost of Revenue | $4.00B | $3.46B | $2.41B | $1.62B | ···· | ···· | ···· | ···· |
| Gross Profit | $574.4M | $488.6M | $296.7M | $201.0M | ···· | ···· | ···· | ···· |
| Research & Development | $0.00 | $0.00 | $0.00 | $0.00 | ···· | ···· | ···· | ···· |
| SG&A Expenses | $252.1M | $0.00 | $371.4M | $307.4M | ···· | ···· | ···· | ···· |
| Operating Expenses | $519.4M | $473.8M | $398.2M | $328.8M | ···· | ···· | ···· | ···· |
| EBITDA | $86.5M | $45.3M | -$77.4M | -$105.3M | ···· | ···· | ···· | ···· |
| Operating Income | $55.0M | $14.8M | -$101.6M | -$127.8M | ···· | ···· | ···· | ···· |
| Interest Expense | $16.2M | $15.8M | $23.5M | $21.2M | ···· | ···· | ···· | ···· |
| Income Before Tax | $38.8M | -$958K | -$128.1M | -$148.2M | ···· | ···· | ···· | ···· |
| Income Tax Expense | -$1.9M | $20K | $21K | -$22K | ···· | ···· | ···· | ···· |
| Net Income | $40.7M | -$724K | -$128.0M | -$148.0M | ···· | ···· | ···· | ···· |
| Basic EPS | $0.20 | $-0.00 | $-0.67 | $-0.79 | ···· | ···· | ···· | ···· |
| Basic Shares | 207M | 198M | 191M | 186M | ···· | ···· | ···· | ···· |
| Diluted Shares | 215M | 198M | 191M | 186M | ···· | ···· | ···· | ···· |
Earnings Summary
Revenue
$1.34B
Estimate unavailable.
Revenue Beat/Miss
Not available (no estimate stored)
EPS
$0.17
Estimate unavailable.
EPS Beat/Miss
Not available (no estimate stored)
Debt Change
+0.3%
Cash Change
+47.5%
Margin Change
+1.2 pp
Debt and cash show percentage changes versus the comparison period; margin shows the change in percentage points (pp). These are company-wide changes, not per-share amounts.
Financial Changes Since Prior Period
What Improved
- Margins expanded
- Cash position grew
What Weakened
- Debt increased
Potential Score Impact
Positive indicators included revenue growth, EPS growth, cash levels, net income margin. Pressure indicators included debt levels. These factors may support or pressure the Revenue, Management, Financial, and Debt categories; this summary does not claim that the stored scores changed.
Stored Earnings Analysis
Revenue increased 31.6%. EPS increased 127.3%. Cash increased 47.5%. Total debt increased 0.3%. Net income margin improved by 1.2 percentage points.
Earnings-Call Transcript
Earnings-call transcript analysis is not currently available.
These results may influence future scores when the next evaluation is completed.
Insider Activity
Guru / Smart Money
Guru Score
Smart Money
Number of Gurus
Total Guru Value
Avg Portfolio Weight
Largest Holder
Largest Holder %
New Positions
Increased Positions
Reduced Positions
Exited Positions
Net Guru Sentiment
Short Interest
Dividend History
Dividend data is not available yet. Missing data does not mean this company pays no dividend.
Conservative Projected Values
3 Years
$———.——
5 Years
$———.——
10 Years
$———.——
Conservative Projection Rate
——%
Conservative Projected Values — price projections derived from actual 10-year adjusted historical returns, conservatively adjusted and capped at 8% annually. These are distinct from the Outperformance Model Score and WallStreetScore.
Conservative Projected Values
Premium unlocks the 3-year, 5-year, and 10-year conservative projected values with full calculation breakdowns based on actual historical returns.
Start 7-Day Free TrialHistorical Outperformance Record
Premium includes stored forecasts and any available evaluated results. Completed results, win rates and calibrated probabilities are shown only when supported records exist; access does not create historical outcomes.
Start 7-Day Free TrialHistorical Trends
5 historical recordsHistorical Score Chart
3 of 5 records shownWall Street Score
Debt Score
Revenue Score
Asset Score
Capital Score
Management Score
Moat Score
Valuation Score
Buffett Score
Intrinsic Value
Value Reference
Margin of Safety %
Related Companies
Medical - Healthcare PlansNews
Investor Notification: Alignment Healthcare ($ALHC) Investors Are Reminded to Contact BFA Law About the Ongoing Securities Fraud Investigation to Recover Losses
ALHC Investigation News: Alignment Healthcare Investors are Notified of the Pending Securities Fraud Investigation – Contact BFA Law if You Lost Money
Analysts Estimate Alignment Healthcare (ALHC) to Report a Decline in Earnings: What to Look Out for
Alignment Health Expands Medicare Advantage Plan to Nye County for 2027
Rumor Mill · ALHC
Corporate developments & opportunities
No reviewed developments match this filter.
Evidence credibility is not a forecast of stock performance. Rumor Mill is separate from the WSS score.
Related Stock Research
Continue researching this company with related Wall Street Score rankings and investing guides.
Score Alerts
Premium unlocks alerts when a score rises, falls, or reaches your target price.
Start 7-Day Free TrialPortfolio Score
Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.
Start 7-Day Free Trial